Getting latest data loading
Home / Blog / blog / Aberdeen Asset Management (ADN): Buy the rumour….sell the fund?

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Aberdeen Asset Management (ADN): Buy the rumour….sell the fund?

26 Oct 2015

Aberdeen Asset Management (ADN) shares are top of the UK Index this morning, benefiting from a prime example of ‘buy the rumour…’ even if said rumour has already been swiftly denied. Weekend press speculation suggested ‘ADN’ had been sounding out buyers after turbulent period for markets linked to global growth expectations and monetary policy which saw profits and assets slump and the share price sink to 3yr lows of 290p. While the shares were already rebounding with the wider market on easy money/stimulus hopes in October, getting back to 330-350p, the spec has seen the shares break out and gap up to levels last seen in late July.

AberdeenDenial from founder and CEO Martin Gilbert is not, however, seeing the other half of the trading adage (‘…sell of the fact’) put pressure on the shares just yet. Short sellers have likely been squeezed out on the recent 20% rebound and don’t fancy another go, recent bottom pickers are holding on hoping their proves to be substance in the speculation while momentum traders are jumping on board in the hope of a quick return to 400p. Will further denial scupper takeover hopes or simply lead to claims of the ‘laddie doth protest too much’.

Mike van Dulken, Head of Research

                                                         

« Back to Category

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research

Comments are closed.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.